4D Molecular Therapeutics Financial Overview
4D Molecular Therapeutics's market cap is currently $455.37M. The company's EPS TTM is $-1.01; its P/E ratio is -2.02; 4D Molecular Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
